Susan G. Komen 3-Day for the Cure
 |
This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (August 2008) |
The Susan G. Komen 3-Day for the Cure, frequently referred to as the 3-Day, is a 60-mile walk to raise funds and awareness to fight breast cancer. Participants commit to fundraising, training, and dedicating a three-day weekend to the event.
Contents |
[edit] About
Taking place in 15 cities in the USA, the 3-Day for the Cure is a series of three-day, 60-mile walk that raise millions of dollars for breast cancer research, education, and community health programs. Breast Cancer 3-Day participants raise a minimum of $2,300 and walk an average of 20 miles a day, educating thousands of people about breast health. Walkers must be at least 16 years old or be accompanied by an adult. Crew members must be at least 18 years old, and volunteers must be at least 10 years old. The Komen 3-Day for the Cure supports its participants before the event by providing coaches, training assistance, fundraising advice and a personal fundraising webpage.
The net proceeds fund breast cancer research, education, and community outreach programs. Since its inception, more than $400 million has been raised.
[edit] Beneficiaries
In 2010, the Breast Cancer 3-Day will be renamed Susan G. Komen 3-Day for the Cure and Susan G. Komen for the Cure will be the sole beneficiary[1] where no money will go to breast cancer screening for poor or minority women or women who belong to the wrong political persuasion.
[edit] History
The first concept for a three day walk for breast cancer was created and produced in 1998 by Dan Pallotta and Pallotta TeamWorks benefitting the Avon Foundation. In late Aug 2002 Avon introduced its own two-day walk (the Avon Walk for Breast Cancer, a 39-mile walk over two days). In 2003, the Breast Cancer 3-Day debuted with current event manager and beneficiary, National Philanthropic Trust, and primary beneficiary, Susan G. Komen for the Cure.
